Zytiga (Janssen Biotech, Inc.)
Welcome to the PulseAid listing for the Zytiga drug offered from Janssen Biotech, Inc.. This Cytochrome P450 17A1 Inhibitors [MoA],Cytochrome P450 17A1 Inhibitor [EPC],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Janssen Biotech, Inc. |
NON-PROPRIETARY NAME: | abiraterone acetate |
SUBSTANCE NAME: | ABIRATERONE ACETATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cytochrome P450 17A1 Inhibitors [MoA],Cytochrome P450 17A1 Inhibitor [EPC],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2011-04-28 |
END MARKETING DATE: | 0000-00-00 |
Zytiga HUMAN PRESCRIPTION DRUG Details:
Item Description | Zytiga from Janssen Biotech, Inc. |
LABELER NAME: | Janssen Biotech, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 250(mg/1) |
START MARKETING DATE: | 2011-04-28 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 57894-150_a7528969-71a7-4264-8424-f456ec43a8bb |
PRODUCT NDC: | 57894-150 |
APPLICATION NUMBER: | NDA202379 |
Other ABIRATERONE ACETATE Pharmaceutical Manufacturers / Labelers: